You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Details for Patent: 10,172,874


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,172,874 protect, and when does it expire?

Patent 10,172,874 protects VABOMERE and is included in one NDA.

This patent has sixty-two patent family members in thirty countries.

Summary for Patent: 10,172,874
Title:Pharmaceutical compositions comprising cyclic boronic acid ester derivatives
Abstract:Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to cyclic boronic acid ester derivatives and their use as therapeutic agents.
Inventor(s):Gavin Hirst, Raja Reddy, Scott Hecker, Maxim Totrov, David C. Griffith, Olga Rodny, Michael N. Dudley, Serge Boyer
Assignee: Melinta Subsidiary Corp
Application Number:US15/935,862
Patent Claim Types:
see list of patent claims
Composition; Compound;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 10,172,874

Introduction

United States Patent 10,172,874 (hereafter "the '874 patent") represents a crucial intellectual property asset within the pharmaceutical patent landscape. Issued on January 8, 2019, the patent protects a specific drug compound or formulation, potentially providing exclusivity for its corresponding pharmaceutical product. This analysis dissects the patent's scope and claims, assesses its strategic significance within the patent landscape, and elucidates implications for competitors and stakeholders.


Scope of the '874 Patent

Key Patent Classification and Subject Matter

The '874 patent is classified under the Cooperative Patent Classification (CPC) system, likely aligning with classes relating to pharmaceuticals, organic compounds, and drug delivery systems. Specifically, the patent covers a novel chemical entity or a novel formulation thereof, designed for a particular therapeutic purpose—commonly targeting specific diseases or conditions such as oncology, neurology, or infectious diseases [1].

Territorial and Patent Term

As a U.S. patent, its scope is geographically limited to the United States, offering protections within that jurisdiction until expiration in roughly 20 years from the earliest filing date, typically around 2037, subject to maintenance fee payments and patent term adjustments [2].

Legal and Technical Scope

The scope encompasses both the compound itself and potentially its pharmaceutical formulations, methods of synthesis, and uses. The patent may include claims covering:

  • The chemical structure of the active compound
  • Specific dosage forms or delivery mechanisms
  • Methods for producing or synthesizing the compound
  • Therapeutic uses and indications

The overall scope hinges on how broad or narrow the claims are drafted, balancing the need for substantial protection against the risk of invalidation or design-around options.


Analysis of the Claims

Independent Claims

The patent likely contains multiple independent claims, which form the core legal protection. For example, one independent claim might cover:

  • A new chemical entity, with a specific molecular formula, and
  • Its pharmaceutical composition, comprising the compound and a suitable excipient, optimized for a particular route of administration.

Alternatively, some independent claims could focus on method of use, such as:

  • A method of treating a disease or disorder with the compound.

Dependent Claims

Dependent claims specify particular embodiments, such as:

  • Specific stereochemistry or isomers
  • More precise dosage ranges
  • Specific combinations with other therapeutic agents
  • Particular methods of synthesis

Claim Drafting Strategies and Implications

The breadth and language of the claims influence enforceability:

  • Broad claims provide extensive protection but are more susceptible to invalidation via prior art.
  • Narrow claims mitigate invalidation risks but can be easier for competitors to design around.

In the case of the '874 patent, if the claims cover a broad chemical class, they may offer significant competitive leverage. Conversely, narrow claims limit scope but may be easier to defend.

Claim Interpretation and Patent Validity

The scope of claims is subject to patent law principles, including means-plus-function interpretation and doctrine of equivalents. The validity of claims depends on novelty, non-obviousness, and adequate disclosure as per 35 U.S.C. § 102, 103, and 112.


Patent Landscape Considerations

Prior Art and Patent Family

The patent landscape for compounds similar to those claimed in the '874 patent involves an extensive prior art review, encompassing:

  • Pre-existing patents and publications disclosing related compounds
  • Scientific literature describing similar chemical structures
  • Prior art methods of synthesis or use

The patent's strength substantially depends on its novelty over the prior art and the inventive step in its claims.

Related Patents and Patent Families

The assignee(s) of the '874 patent may have filed international or regional patents within the same family, covering:

  • Variations or derivatives of the compound
  • Complementary formulations
  • Manufacturing processes

The patent family expands IP coverage, enforcing territorial rights and possibly creating a patent thicket that complicates generic entry.

Patent Expiry and Expanding the Landscape

Given the filing date (likely in 2018 or earlier), the patent is nearing the latter part of its term. However, patent term adjustments or subsequent filings could extend protection or create new patents in related inventions.

Legal Status and Opposition

The patent's legal status is critical. It could have faced office actions, oppositions, or reexaminations, which might narrow its scope or invalidate certain claims, affecting the patent landscape.


Strategic and Commercial Implications

The '874 patent's scope and claims determine its commercial strength:

  • If claims are broad, the patent can serve as a formidable barrier to generic competition.
  • Narrow claims could allow competitors to develop alternative compounds or formulations.
  • The patent landscape, including related patents, influences freedom-to-operate and potential licensing opportunities.

Manufacturers and investors must assess patent strength, potential for challenges, and market exclusivity based on these factors.


Key Takeaways

  • The '874 patent secures rights over a novel chemical entity or formulation, with precise claims that define its exact scope.
  • Broader claims amplify market exclusivity but risk invalidation; narrower claims offer limited scope but stronger defensibility.
  • The patent landscape surrounding the '874 patent includes related patents, prior art, and potential patent thickets that influence market entry.
  • Ongoing patent prosecution and potential legal challenges may alter the enforceability and scope over time.
  • Strategically, the patent's strength supports market exclusivity, partnerships, and licensing efforts, provided it withstands legal scrutiny.

FAQs

1. What is the main innovation protected by U.S. Patent 10,172,874?
The patent protects a specific chemical compound or formulation that demonstrates novel therapeutic properties, the exact nature of which is detailed in its claims.

2. How broad are the claims of the '874 patent?
The breadth depends on the patent’s claims drafting; they may range from covering a broad class of compounds to specific chemical structures or formulations.

3. Can competitors develop similar drugs around this patent?
Yes, if claims are narrow or specific, competitors can attempt to modify the compound or formulation to avoid infringement. The scope of the claims governs infringement risk.

4. What is the potential lifespan of this patent's protection?
Typically, U.S. patents last 20 years from the earliest filing date, subject to maintenance fees and any patent term adjustments.

5. How does the patent landscape influence the commercial strategy of the patent owner?
It determines the market exclusivity, potential licensing opportunities, and risks of patent challenges, influencing R&D directions and investment decisions.


References

[1] US Patent Classification. Cooperative Patent Classification (CPC).
[2] United States Patent and Trademark Office (USPTO). Patent Term and Maintenance Fees.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 10,172,874

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Rempex VABOMERE meropenem; vaborbactam POWDER;INTRAVENOUS 209776-001 Aug 29, 2017 RX Yes Yes 10,172,874 ⤷  Get Started Free Y ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,172,874

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2603514 ⤷  Get Started Free 300977 Netherlands ⤷  Get Started Free
European Patent Office 2603514 ⤷  Get Started Free 300978 Netherlands ⤷  Get Started Free
European Patent Office 2603514 ⤷  Get Started Free 122019000027 Germany ⤷  Get Started Free
European Patent Office 2603514 ⤷  Get Started Free CA 2019 00015 Denmark ⤷  Get Started Free
European Patent Office 2603514 ⤷  Get Started Free CA 2019 00016 Denmark ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.